Application 204912
- Type
- ANDA
- Sponsor
- AKORN INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TIMOLOL MALEATE | TIMOLOL MALEATE | SOLUTION;OPHTHALMIC | 0.5% | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Timolol Maleate | TIMOLOL MALEATE | Rising Pharma Holdings, Inc. | 0bc40b2c-65eb-4095-87e6-4752d5b19a3a | 2024-06-11 | Warnings, Adverse reactions | Timolol Maleate TIMOLOL MALEATE |
| TIMOLOL MALEATE | TIMOLOL MALEATE | A-S Medication Solutions | 1ffd9ed1-8ab4-4036-bbc6-dcf58e659248 | 2024-06-03 | Warnings, Adverse reactions | TIMOLOL MALEATE TIMOLOL MALEATE |
| Timolol GFS | TIMOLOL MALEATE | Sandoz Inc | 72b0d0ec-832a-4c25-b845-2537ab506354 | 2024-05-28 | Warnings, Adverse reactions | TIMOLOL MALEATE |
| TIMOLOL MALEATE | TIMOLOL MALEATE | Aurobindo Pharma Limited | e6c74f66-ee84-4bcc-b1da-b8e6ff240dd2 | 2024-05-16 | Warnings, Adverse reactions | TIMOLOL MALEATE TIMOLOL MALEATE |
| TIMOLOL MALEATE | TIMOLOL MALEATE | Pacific Pharma, Inc. | e16c33fd-aa86-49ad-a767-c79ade4a62c7 | 2024-03-14 | Warnings, Adverse reactions | TIMOLOL MALEATE TIMOLOL MALEATE |
| timolol maleate | TIMOLOL MALEATE | First Nation Group, LLC | 140e1bfc-b75e-40d1-856c-242be4d9c8cc | 2024-03-07 | Warnings, Adverse reactions | timolol maleate TIMOLOL MALEATE |
| Timolol Maleate | TIMOLOL MALEATE | Ingenus Pharmaceuticals, LLC | 4c4318b3-9865-4172-a7bd-9e68913eca1e | 2023-10-25 | Warnings, Adverse reactions | Timolol Maleate TIMOLOL MALEATE |
| timolol maleate | TIMOLOL MALEATE | Lifestar Pharma LLC | 545b7bee-8d5d-4206-b973-8de3c14d6dfe | 2023-07-03 | Warnings, Adverse reactions | timolol maleate TIMOLOL MALEATE |
| Timoptic | TIMOLOL MALEATE | Bausch & Lomb Incorporated | 45ac65b3-19f7-4f33-aebf-cadd3daa4bf1 | 2022-04-30 | Warnings, Adverse reactions | TIMOLOL MALEATE |
| Timoptic-XE | TIMOLOL MALEATE | Bausch & Lomb Incorporated | a4d03de7-06b7-4cfc-9d1b-616969df209c | 2022-03-31 | Warnings, Adverse reactions | TIMOLOL MALEATE |
| Timoptic in Ocudose | TIMOLOL MALEATE | Bausch & Lomb Incorporated | d130f0ec-c3b5-4bc3-8f4a-68fd6c3ec0cf | 2022-01-31 | Warnings, Adverse reactions | TIMOLOL MALEATE |
| Timolol Maleate | TIMOLOL MALEATE | Mylan Pharmaceuticals Inc. | 57c62928-63d8-4505-9b9e-c085a3a12c95 | 2020-07-06 | Warnings, Adverse reactions | Timolol Maleate TIMOLOL MALEATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.